Abbott Laboratories (ABT) Change in Acquisitions & Divestments (2017)
Abbott Laboratories recorded quarterly Change in Acquisitions & Divestments of -$1.8 billion in Q4 2017, down 3586.79% quarter-over-quarter from $53.0 million in Q3 2017.
Abbott Laboratories' Change in Acquisitions & Divestments history runs 1 years deep, the most recent figure standing at -$1.8 billion for Q4 2017.
- In Q4 2017, Change in Acquisitions & Divestments changed N/A year-over-year to -$1.8 billion; the TTM figure through Dec 2017 stood at $129.0 million (changed N/A YoY), while the FY2025 annual figure was $3.0 million, down 89.29% from the prior year.
- Change in Acquisitions & Divestments came in at -$1.8 billion for Q4 2017 at Abbott Laboratories, down from $53.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.7 billion in Q1 2017 to a low of -$1.8 billion in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | -1.85 Bn |
| Dec 31, 2017 | -1.85 Bn |
| Sep 30, 2017 | 53.00 Mn |
| Sep 30, 2017 | 53.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Jun 30, 2017 | 239.00 Mn |
| Mar 31, 2017 | 1.69 Bn |
| Mar 31, 2017 | 1.69 Bn |